Bio-Rad Laboratories, Inc. (BIO) vs Universal Health Services, Inc. (UHS)
UHS leads on 14 of 14 compared metrics.
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 26, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BIO
Bio-Rad Laboratories, Inc.
$298.29Healthcare
UHS
Universal Health Services, Inc.
$145.69Healthcare
Total return — BIO vs UHS
growth of $100 · last 30yBIO +1621.0%UHS +2141.4%UHS compounded faster
BIO UHS
BIO vs UHS: by the numbers
- •UHS is the larger company ($9.12B vs $8.00B market cap).
- •UHS trades at the lower earnings multiple (6.11 vs 49.14 P/E).
- •UHS converts more revenue to profit (8.56% vs 6.52% net margin).
- •UHS grew revenue faster over the past five years (8.63% vs -0.84% CAGR).
- •UHS pays a dividend (0.55% yield) while BIO does not currently pay one.
Which is better, BIO or UHS?
Metric tally: BIO 0 · UHS 14It depends on what you're optimizing for:
ValueUHS(lower P/E)
GrowthUHS(faster 5Y revenue CAGR)
QualityUHS(higher ROIC)
Metrics side by side
Valuation
| Metric | BIO | UHS |
|---|---|---|
| P/E ratio | 49.14 | 6.11● |
| Forward P/E | 29.93 | 6.21● |
| P/S ratio | 3.10 | 0.51● |
| P/B ratio | 1.17 | 1.19 |
| PEG ratio | — | 0.26 |
| EV / EBITDA | 20.37 | 5.25● |
| FCF yield | 4.44% | 9.94%● |
Profitability
| Metric | BIO | UHS |
|---|---|---|
| Gross margin | 51.87% | 90.45%● |
| Operating margin | 9.25% | 11.50%● |
| Net margin | 6.52% | 8.56%● |
| ROE | 2.46% | 20.19%● |
| ROIC | 2.04% | 11.29%● |
Dividends
| Metric | BIO | UHS |
|---|---|---|
| Dividend yield | — | 0.55% |
| Payout ratio | — | 3.42% |
Growth (annualized)
| Metric | BIO | UHS |
|---|---|---|
| Revenue CAGR (5Y) | -0.84% | 8.63%● |
| EPS CAGR (5Y) | -26.27% | 16.19%● |
| FCF CAGR (5Y) | -7.57% | -4.64%● |
| Total return CAGR (5Y) | -14.13% | -0.22%● |
Frequently asked
- Which is better, BIO or UHS?
- It depends on your goal. value: UHS (lower P/E); growth: UHS (faster 5Y revenue CAGR); quality: UHS (higher ROIC). Across all compared metrics, UHS leads 14 to 0.
- Is BIO or UHS cheaper?
- On trailing earnings, UHS is cheaper: BIO trades at a 49.14 P/E and UHS at 6.11.
- Which has grown faster, BIO or UHS?
- Over the past five years, UHS grew revenue faster — BIO at a -0.84% CAGR versus UHS at 8.63%.
- Does BIO or UHS pay a bigger dividend?
- UHS pays a dividend (0.55% yield) while BIO does not currently pay one.
- Is BIO or UHS more profitable?
- UHS runs the higher net margin — BIO at 6.52% versus UHS at 8.56%.
- Which has been the better investment, BIO or UHS?
- Over the past 10-year, BIO delivered the higher annualized total return — BIO at 7.86% versus UHS at 1.10%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioUniversal Health Services P/E ratioBio-Rad Laboratories dividend yieldUniversal Health Services dividend yieldBio-Rad Laboratories ROEUniversal Health Services ROEBio-Rad Laboratories operating marginUniversal Health Services operating marginBio-Rad Laboratories revenue growthUniversal Health Services revenue growthBio-Rad Laboratories free cash flowUniversal Health Services free cash flow
Bio-Rad Laboratories & Universal Health Services appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 26, 2026.